OrthoStreams – Top 10 in Medical Devices on LinkedIn

LinkedIn’s Top 10 Med Device Posters of 2016
2016 was a busy year on LinkedIn. Despite the increase in political posts, marketing gimmicks, and pictures of questionable professionalism, a few stellar individuals and companies stood out as producers of impactful content or examples of effective personal or professional brand development on LinkedIn. These champions of 2016 can serve as a great example of what you can do to impact your brand if you make investments over time in this powerful medium.
As someone who published over 40 articles as well as starting a blog, youtube channel, and podcast, I think am well qualified to understand the investment made by these exceptional LinkedIn users. These exceptional individuals and companies can help motivate you to create ideas to optimize your LinkedIn brand.
#1 Stryker Medical
Stryker has done an exceptional job in producing high-quality content and regularly posting. 2016 started strong with a well-written post from their CVP of HR, and they continued their support of employer branding on LinkedIn throughout the year with excellent employee profiles and warm, engaging content.
#2 Tandem Diabetes
Tandem makes themselves look bigger and more established through LinkedIn. Honestly, I was surprised to find out how small they are. Who would think that they are a 70-million-dollar market cap company? They create a big presence by posting impactful product and patient stories.
#3 Rami Elghandour – CEO at Nevro
As CEO and president of a fast-growing public medical device company, Rami is an extremely busy guy. Despite a grueling schedule, Rami manages to post on LinkedIn daily. He rarely creates new content or comments, but his consistency and value-added content sharing has catapulted him to one of the most viewed med device profiles.
#4 Joe Mullings – CEO Mullings Group
Joe is a colorful character on LinkedIn. Since Mid-Year, he has significantly upped his game. He definitely uses a few tricks like constantly changing his profile pic. He and his team are producing high-quality videos and articles that benefit his visibility and can help educate med device professionals.
#5 Joe Hage – Medical Device Marketing Consultant and Leader of the Medical Device Group
With over 9,000 personal connections and 340,000 members of the Medical Device Group, Joe has used LinkedIn to establish a discernable position for himself.
#6 Paul Molloy – CEO ClearFlow
Paul is what I would call a CEO evangelist. He effectively uses LinkedIn to educate the market on ClearFlow and to preach the benefits of their product.
#7 Kelly Bryant – Talent Acquisition LivaNova
Kelly rarely creates her own original content, but she is a master of the repost. She keeps herself visible through her connections’ streams by regularly reposting value-added recruitment training content.
#8 Tiger Buford – Tiger Recruiting
Tiger is a med device executive turned headhunter and a master of Orthopeadics. With his informative Orthostreams.com website and strategic use of LinkedIn updates, Tiger has created a very effective recruitment system.
#9 Jeffrey Schell – President Trans S1
Jeff brings Trans S1 to life with his interactive and consistent postings of high-quality content.
#10 Johnson & Johnson
In a corporate and somewhat robotic way, J&J made its way onto the list. They definitely follow a very rigid social media policy, but they still manage to consistently post content and brand themselves. They also do a good job of having multiple recruiters create a solid LinkedIn presence.
That wraps up our 2016 list. Will you be on our list in 2017? By following the examples demonstrated by these titans of LinkedIn, you can build your own brand and meet your goals.
Please like and share this post!
Mike Adamo is the medical device industry’s top headhunter and a business author.
Search Firm – www.MedDeviceTalent.com
Blog – www.mradamo.com
Youtube – http://tinyurl.com/zdr8sho
Podcast – http://meddevicetalent.podbean.com/
Amazon Author Page – https://www.amazon.com/Mike-Adamo/e/B01LYY2MIH

Read More

Keep your eye on Trice Medical!

I am constantly looking for highly disruptive technology companies in orthopedics.  Trice Medical is one.  I am a big fan of Trice. I am calling this one early!  Trice Medical will be a highly successful startup.  In many ways, Trice reminds me of my last successful disruptive startup, Ellipse Technologies.
WHAT IS TRICE DOING?
Trice Medical sells an “in-the-office diagnostic arthroscopy“.  The mi-eye 2™system is fully integrated with a camera, light source, and cannula. It connects to a tablet for visualization.  Trice Medical provides the mi-eye 2™ handheld system for a diagnosis of any joint diagnosis with direct visualization within minutes for less than an MRI.  Instantly, the patient can have a proper diagnosis of the soft tissues inside the joint in minutes, no waiting.
I believe that Trice will both delay and replace expensive timely MRI diagnoses as orthopedists discover this tool over time. In the company’s own words, “Now, physicians can provide realtime analysis, effect faster treatment, and schedule patients for surgery immediately – resulting in quicker outcomes for patients and a more efficient process for doctors.”
 

https://www.youtube.com/watch?v=lcO9UbxZPRE
VIDEO from CBS News…  http://newyork.cbslocal.com/2016/12/09/tiny-cameras-knee-surgery/
MORE ABOUT mi-eye 2™

An injured knee or shoulder can take weeks to visualize and diagnose with an MRI. mi-eye 2 is faster, providing real-time, vivid imaging that benefits both patient and doctor with the answers necessary to determine the best treatment – in just one visit.
mi-eye 2 empowers physicians with answers in just one consultation. The result is that patients can be scheduled for surgery immediately.
mi-eye 2 helps doctors eliminate the fine line between physical therapy and surgery with an immediate visualization. Instant results help patients recover up to two weeks faster than when choosing an MRI. * *Based on estimated time-frame from radiology testing and results, including follow-up consultation.
A wide, 120° viewing angle empowers doctors with the expanded perspective they need to visualize and confirm joint injuries.
mi-eye 2 presents a vivid picture on a large, HD Microsoft tablet – with striking resolution for an accurate diagnosis.
Doctors and patients can watch mi-eye 2’s impressive visualization in real-time on an HD screen. There is no better way to demonstrate the nature of an injury – or to put a patient at ease.
mi-eye 2™ provides surgeons and patients with immediate, eyes-on, answers to the condition of the intra-articular joint space. mi-eye 2 is a fully disposable, single-use device that is delivered in sterile packaging and ready for immediate application.
Optimized for use in the orthopedic office setting, mi-eye 2™ delivers immediate visualization, practice friendly ease of use, and a simple streamlined procedure.

MORE ABOUT TRICE MEDICAL
Trice Medical was founded to fundamentally improve orthopedic diagnostics for the patient, physician, and payor by providing instant, eyes-on, answers.  Trice Medical has pioneered fully integrated camera-enabled technology, the mi-eye 2™, that provides a clinical solution optimized for the physician’s office.  Trice Medical’s mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system. Trice Medical is a venture capital backed company; Safeguard Scientifics (NYSE: SFE), BioStar Ventures and HealthQuest Capital are its major investors; smaller firms and angel investors have completed the rounds. 
For more information, visit www.tricemedical.com; follow us on Twitter, LinkedIn and Facebook or call 610-989-8080.

Read More

Axiomed is Raising Interest from Silicon Valley

Axiomed is Raising Interest from Silicon Valley (press release)
Aditya Humad, Acting CFO of AxioMed and Managing Partner of KICVentures, is pleased to announce that in addition to Australia, Europe, and the United States, Axiomed is now gaining interest from Silicon Valley. “It was satisfying to complete the due diligence required to assure interest in this technology.”
Mr. Humad went on to say that, “We expect interest to continue to rise as AxioMed completes its cleanroom assembly to begin manufacturing the cervical and lumbar viscoelastic disc for international distribution to meet an anticipated high demand.” AxioMed completed its IDE in August 2016 and is preparing a submission to the FDA for the clearance of its viscoelastic lumbar disc.
Dr. Kingsley R. Chin, Acting CEO of AxioMed and Managing Partner at KICVentures has been spending more time in Silicon Valley and is quoted as saying, “I feel I share a lot in common with the entrepreneurs in Silicon Valley. I have a tremendous respect for their accomplishments in a broad range of technologies and I feel they have a lot of respect for my knowledge, track record, and experience in health technology. Experts in Silicon Valley have expressed the importance of the potential disruption the seems eminent within healthcare. Time and time again, I get the feedback that AxioMed’s viscoelastic technology seems intuitive over all other existing technologies for spine surgery. They also feel that the clinical and biomechanical results so far are very convincing. I expect interest to build as we demonstrate continued progress.”
About AxioMed
Founded in 2001, AxioMed (http://www.axiomed.com/) began its journey of exhaustively proving the Freedom® Disc through clinical studies in the USA and Europe, research, development and testing. In 2014, KICVentures recognized the disc’s enormous potential and acquired the company into their healthcare portfolio. AxioMed owns an exclusive viscoelastic material license on its proprietary Freedom Disc technology.
 
 

Read More

5 Trends to watch with the top 10 Orthopedic Companies

Top Orthopedic Firms and Trends From 2014 to 2020 (QMED byKristopher Sturgis)
The orthopedic industry will likely see some significant changes over the next few years. Here are some of the key trends facing the industry, and a brief overview of which companies are leading now, and which are projected to lead in 2020.
 
 
With worldwide medtech sales expected to reach $477.5 billion by 2020, the orthopedic device market looks to remain a major player. The industry is slated to rank 3rd in sales behind only cardiology and in vitro diagnostics, according to the analyst firm EvaluateMedTech.
The giants of the industry look to remain largely unchanged as well, as Johnson & Johnson is expected to remain the world’s leading orthopedic company. However, the merger of of Zimmer and Biomet in June of this year could shuffle the landscape by 2020, as the industry continues to adapt to emerging companies and technologies.

 
From company mergers and new growing markets, to regulatory uncertainty and other industry challenges—we’ve decided to take a look into some of the top orthopedic firms, as well as some of the industry trends as forecasted by EvaluateMedTech.
1. The Significant Challenges Facing The Industry
Orthopedic devices raked in $34.8 billion worldwide in 2014, a mark that earned them 4th in medtech industry sales last year. While the forecast over the next five years predicts that the industry will jump into the top three markets alongside cardiology and in vitro diagnostics , the most recent figures indicate that orthopedics will actually lose about 0.5% of the worldwide market share it currently has by 2020.
With more orthopedic companies relying on third party manufacturers, and regulatory bodies becoming increasingly more risk-averse when it comes to orthopedic implants and devices, agencies like the FDA and the British Standards Institution (BSI) have been coming down hard on firms with poorly managed manufacturing operations. The continued uncertainty surrounding regulation in the sector could become a significant factor in the industry in the coming years.
Between now and 2020, the orthopedic sales market has an expected compound annual growth rate (CAGR) of 3.2%, a figure that has dropped a fair amount from last year’s 4.9%forecast. However, the increased availability of emerging technologies such as robotics, 3D printing, and customizable implants could fuel that growth in the next few years.
2. The Market is Growing Faster in Asia
As we all know, innovation and design are two major driving forces that can create growth and opportunity in medtechmarkets. Recent advancements in nanotechnology, robotics, smart implants, 3D printing, and a myriad of other fields will help the orthopedic device market grow exponentially over the next five years, with the Asia-pacific region becoming a particular hotbed for growth and innovation.
The Asia-pacific region is expected to have the highest annual growth rate (CAGR) in the orthopedic device market than any other geographical region between now and 2020, according to the analyst firm Research and Markets. The region is predicted to see unprecedented growth due to increased healthcare awareness, improved economic growth, and increased government funding. Joint ventures and some significant mergers and acquisitions are expected to play a major role in their market growth over the next few years.
3. Zimmer Biomet Rises Up Through the Ranks
After the merger of Zimmer and Biomet in June of this year, the company (known simply as Zimmer Biomet) is projected to jump seven spots from its 2014 rank in worldwide medtech sales, peaking at 13th in the rankings by 2020.
With an expected growth in orthopedic sales of 10.5% per year (CAGR) between now and 2020, Zimmer Biomet is predicted to have the second largest annual growth rate of any of the top companies in the orthopedic sales industry. The company is expected to bring in worldwide sales  of over $8 billion by 2020, nearly double their 2014 output of $4.4 billion.
According to the analyst firm EvaluateMedTech, Zimmer Biomet is projected to leapfrog Stryker in the list of top 10 orthopedic companies, settling in at number two behind only Johnson & Johnson as the world’s leading orthopedic company.
4. Johnson & Johnson Remains the Orthopedic King…For Now
As mentioned in the last section, the general consensus is that Johnson & Johnson will remain the world’s leading orthopedic company, with worldwide orthopedic sales projected to top out at over $10.5 billion by 2020. Johnson & Johnson dominated the market in 2014 when they doubled the worldwide sales figures of every other company on the market except Stryker, whom they still outsold by no slim margin.
However, the emergence of Zimmer Biomet will be one to keep an eye on as industry analysts have predicted that this year’s merger could see the company nearly double their 2014 sales figures, topping out at over $8 billion by 2020. Meanwhile, Johnson & Johnson is also expected to see their market share fall from 26.1% in 2014 to 25% by 2020.
5. Robotics, Custom Implants, and 3D Printing Are Taking Off   
Some of the emerging technologies in the orthopedics field could also play a major role in the shaping of the market in the next few years. Robotics and computer navigated surgeries continue to gain momentum as robotic and advanced computer technologies are used in knee and joint replacement surgeries, as well as cartilage repair procedures.
Customized implants are also increasing in the market as the demand for patient-specific implantation rises. Major companies like Stryker, Zimmer Biomet, Medtronic, and many others are now involved in the manufacturing of personalized orthopedic devices and implants.
3D printing also continues to shape the landscape of orthopedic sales, as custom orthopedic instruments continue to be among the most popular applications in the world of 3-D printing. The technology can be used to produce cutting and drilling guides for knee replacements, custom implant devices, and even internal fixation devices such as screws and plates.
 

Read More

Medtronic formally jumps into the total joint segment with a total knee replacement and program

READ more about the acquisition that set this up –> Doug Kohrs does it again! Medtronic acquires his low-cost hip and knee startup
 
Medtronic targets Medicare bundled payments with knee replacement offering (MassDevice)
Medtronic (NYSE:MDT) said today that it’s getting into the large joint replacement business, aiming to capitalize on a new bundled payment program at the Centers for Medicare & Medicaid Services.
The government insurer announced its 5-year “Comprehensive Care for Joint Replacement” program in July 2015, saying it would involve more than 800 hospitals in 75 geographic areas. The CJR program, which went into effect in January, bundles payments for hip and knee replacements from hospital admission to 90 days after discharge. The payment covers “all related items and services paid under Medicare Part A and Part B for all Medicare fee-for-service beneficiaries,” CMS said at the time.
Reimbursement is also pegged to outcomes and cost, giving Medicare the ability to claw back payments or reward good performance with addition payments; the CJR program aims to save about $150 million over 5 years.
Today Medtronic said its new Orthopedic Solutions business, launching with a total knee arthroplasty solution, aims to help surgeons through the CJR process from pre-surgical planning through the 90-day post-discharge period. The knee offering debuted this week at the annual meeting of the American Assn. of Knee & Hip Surgeons; the Fridley, Minn.-based company said it expects the knee offering to be “widely available” in the 1st half of next year.
“Medtronic is here to help speed the adoption of value-based healthcare in orthopedics by helping hospitals drive down costs while keeping outcomes top of mind,” restorative therapies president Geoff Martha said in prepared remarks. “Our technological and operational efficiency know-how – along with our insight into the various points along the care continuum – helps us develop effective solutions, tailored to client needs. And we back this up by sharing potential savings with our customer, which means we get paid if our program is successful in reducing episode costs for customers. This is about more than just offering implants or individual technologies and services; it’s about partnering with all stakeholders throughout the entire episode of care to enable patient-centered care at the best value.”
“Quality, lower-cost implants are a very attractive option as we seek to improve patient’s lives while also providing value-driven healthcare,” added Dr. Richard Scott, emeritus professor of orthopedic surgery at Harvard Medical School, a co-designer of Medtronic’s knee system. “We designed Medtronic’s total knee arthroplasty system to be simple, versatile and intuitive without unnecessary complexity and inventory. The goal is to benefit everyone – 1st and foremost the patients, but also the surgeons, hospitals and payers who are providing their care.”

Read More

Technology, Startup News, Career Advice & More

Archives

Pin It on Pinterest

Menu